Xenetic Biosciences, Inc is a biotechnology business based in the US. Xenetic Biosciences shares (XBIO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Xenetic Biosciences employs 4 staff and has a trailing 12-month revenue of around $436,942.
How to buy shares in Xenetic Biosciences
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: XBIO in this case.
- Research Xenetic Biosciences shares. The platform should provide the latest information available.
- Buy your Xenetic Biosciences shares. It's that simple.
What's in this guide?
- Can I buy shares in Xenetic Biosciences?
- Xenetic Biosciences shares summary
- Compare share dealing platforms
- Is Xenetic Biosciences stock a buy or sell?
- Can I short Xenetic Biosciences shares?
- Are Xenetic Biosciences shares over-valued?
- Xenetic Biosciences's financials
- How volatile are Xenetic Biosciences shares?
- Does Xenetic Biosciences pay a dividend?
- Have Xenetic Biosciences shares ever split?
- Other common questions
Xenetic Biosciences share priceUse our graph to track the performance of XBIO stocks over time.
Xenetic Biosciences shares at a glance
|Latest market close||$N/A|
|52-week range||$0.76 - $3.84|
|50-day moving average||$2.3166|
|200-day moving average||$1.8969|
|Wall St. target price||$5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-12.323|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Xenetic Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Xenetic Biosciences under- or over-valued?
Valuing Xenetic Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Xenetic Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Xenetic Biosciences's P/E ratio
Xenetic Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Xenetic Biosciences shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Xenetic Biosciences financials
|Gross profit TTM||USD$436,942|
|Return on assets TTM||-16.9%|
|Return on equity TTM||-74.03%|
|Market capitalisation||USD$16.4 million|
TTM: trailing 12 months
How to short and sell Xenetic Biosciences shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "XBIO.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 96,873 Xenetic Biosciences shares held short by investors – that's known as Xenetic Biosciences's "short interest". This figure is 23.1% down from 125,985 last month.
There are a few different ways that this level of interest in shorting Xenetic Biosciences shares can be evaluated.
Xenetic Biosciences's "short interest ratio" (SIR)
Xenetic Biosciences's "short interest ratio" (SIR) is the quantity of Xenetic Biosciences shares currently shorted divided by the average quantity of Xenetic Biosciences shares traded daily (recently around 269091.66666667). Xenetic Biosciences's SIR currently stands at 0.36. In other words for every 100,000 Xenetic Biosciences shares traded daily on the market, roughly 360 shares are currently held short.
However Xenetic Biosciences's short interest can also be evaluated against the total number of Xenetic Biosciences shares, or, against the total number of tradable Xenetic Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Xenetic Biosciences's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Xenetic Biosciences shares in existence, roughly 10 shares are currently held short) or 0.0121% of the tradable shares (for every 100,000 tradable Xenetic Biosciences shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Xenetic Biosciences.
Find out more about how you can short Xenetic Biosciences stock.
Xenetic Biosciences share dividends
We're not expecting Xenetic Biosciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have Xenetic Biosciences's shares ever split?
Xenetic Biosciences's shares were split on a 1:12 basis on 24 June 2019. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Xenetic Biosciences shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Xenetic Biosciences shares which in turn could have impacted Xenetic Biosciences's share price.
Xenetic Biosciences share price volatility
Over the last 12 months, Xenetic Biosciences's shares have ranged in value from as little as $0.76 up to $3.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xenetic Biosciences's is 2.5262. This would suggest that Xenetic Biosciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Xenetic Biosciences overview
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. The company is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Frequently asked questions
More on investing
Companies are going public via direct listings and IPOs. Which should you invest in?Read more…
Biden’s plan to replace the federal fleet with American-made electric vehicles gives another boost to a red-hot sector led by Tesla.Read more…
Cruise ship stocks are sailing through murky waters, but can they rise?Read more…
More guides on Finder
How to buy Sanofi stock in Canada | $45.8
Steps to owning and managing SNY, with 24-hour and historical pricing before you buy.
How to buy NorthWestern Corporation stock in Canada
Steps to owning and managing NorthWestern Corporation stocks, with 24-hour and historical pricing before you buy.
How to buy Noble Corporation stock in Canada
Steps to owning and managing Noble Corporation stocks, with 24-hour and historical pricing before you buy.
How to buy NMI stock in Canada
Steps to owning and managing NMI stocks, with 24-hour and historical pricing before you buy.
How to buy nLIGHT stock in Canada
Steps to owning and managing nLIGHT stocks, with 24-hour and historical pricing before you buy.
How to buy NIO stock in Canada | $46.81
Steps to owning and managing NIO stocks, with 24-hour and historical pricing before you buy.
How to buy Nielsen stock in Canada
Steps to owning and managing Nielsen stocks, with 24-hour and historical pricing before you buy.
How to buy Newtek Business Services stock in Canada
Steps to owning and managing Newtek Business Services stocks, with 24-hour and historical pricing before you buy.
How to buy New Fortress Energy stock in Canada
Steps to owning and managing New Fortress Energy stocks, with 24-hour and historical pricing before you buy.
How to buy NeoGenomics stock in Canada
Steps to owning and managing NeoGenomics stocks, with 24-hour and historical pricing before you buy.